EUVIMEDEUVIMED entdecken
Crossref

Combination of baicalein and docetaxel additively inhibits the growth of non-small cell lung cancer in vivo

Linwei Lu, Zhengxiao Zhao, Lumei Liu, Weiyi Gong, Jingcheng Dong

Traditional Medicine and Modern Medicine · 2018

DOI: 10.1142/s2575900018500131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Traditional Medicine and Modern Medicine, 2018. Verfasst von Linwei Lu und 4 weiteren Autor:innen. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objective of this study is to preliminarily evaluate the efficacy of the combination of baicalein and docetaxel on non-small cell lung cancer (NSCLC) in vivo.

Methods

The subcutaneous model was established by inoculation of A549 cells, and then these tumor-bearing mice were randomly assigned to eight groups to receive normal saline (NS) as control, baicalein alone, Taxotere[Formula: see text] (docetaxel injection) alone or the combination of baicalein and Taxotere[Formula: see text]. The effect of the combination treatment was evaluated by [Formula: see text] value. Tumors were harvested for TUNEL and CD31 immunohistochemical staining and important organs for H&E staining.

Results

Baicalein 50[Formula: see text]mg/kg plus docetaxel 10[Formula: see text]mg/kg significantly reduced tumor weight and inhibited the growth rate of tumor, displaying the additive effect indicated by the [Formula: see text] value. Increased apoptosis and decreased tumor angiogenesis also provided pathological evidence. Additionally, baicalein 50[Formula: see text]mg/kg plus docetaxel 10[Formula: see text]mg/kg did not increase toxicity in lung, liver and kidney.

Conclusion

Baicalein 50[Formula: see text]mg/kg plus docetaxel 10[Formula: see text]mg/kg additively inhibits the growth of NSCLC in vivo, and the mechanism underlying remains to be discovered.

Zitieren

APA

Lu, L., Zhao, Z., Liu, L., Gong, W., & Dong, J. (2018). Combination of baicalein and docetaxel additively inhibits the growth of non-small cell lung cancer in vivo. Traditional Medicine and Modern Medicine. https://doi.org/10.1142/s2575900018500131

Vancouver

Lu L, Zhao Z, Liu L, Gong W, Dong J. Combination of baicalein and docetaxel additively inhibits the growth of non-small cell lung cancer in vivo. Traditional Medicine and Modern Medicine. 2018. doi:10.1142/s2575900018500131

BibTeX
@article{Lu2018,
  author = {Lu, Linwei and Zhao, Zhengxiao and Liu, Lumei and Gong, Weiyi and Dong, Jingcheng},
  title = {Combination of baicalein and docetaxel additively inhibits the growth of non-small cell lung cancer in vivo},
  journal = {Traditional Medicine and Modern Medicine},
  year = {2018},
  doi = {10.1142/s2575900018500131}
}
Kostenlos starten →